Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial.

Hongrui MaYaqin GuTingting BianHaiqing SongZhi LiuXun-Ming JiJiangang Duan

Published in: International journal of stroke : official journal of the International Stroke Society (2024)

These findings regarding efficacy and safety support the consideration of dabigatran etexilate therapy as a viable treatment option for Chinese patients with CVT.

Keyphrases

atrial fibrillation
randomized controlled trial
study protocol
subarachnoid hemorrhage
venous thromboembolism
direct oral anticoagulants
replacement therapy
cell therapy